# SCRIMED Market Execution Engine

SCRIMED Market Execution Engine converts public, clean-room competitive research into original SCRIMED product packaging, proof artifacts, sales motions, revenue levers, privacy controls, public-relations language, and investor narratives. It does not copy competitor code, proprietary workflows, private APIs, pricing sheets, UI, branding, logos, datasets, model weights, customer proof, regulatory approvals, certification claims, or production integration claims.

## Scorecard
- Market signal freshness: 88
- Clean-room discipline: 96
- Buyer conversion readiness: 89
- Revenue activation readiness: 86
- Investor narrative readiness: 90
- Privacy trust readiness: 91
- Public relations readiness: 84
- Production readiness: false

## Execution Lanes
- proof-before-pilot-command: priority=immediate; audience=hospital executives, MSOs, faith-based clinics, and investor reviewers; proof=buyer-proof-packet-completeness; next=Add a proof-before-pilot packet to Pilot Deal Room that pulls from QA Evidence, Competitive Intelligence, and Security Diligence Evidence.
- trust-center-as-sales-asset: priority=immediate; audience=enterprise security reviewers, compliance teams, procurement, and legal reviewers; proof=security-diligence-evidence-ready-count; next=Link Security Diligence Evidence Packet into Trust Center and buyer deal-room packet manifests.
- connector-trust-catalog: priority=near-term; audience=implementation sponsors, interoperability partners, health IT leaders, and CTOs; proof=connector-readiness-label-coverage; next=Add connector trust catalog data to interoperability fixture cards and deployment profile pages.
- payer-policy-evidence-loop: priority=immediate; audience=revenue-cycle leaders, payer operations, prior-auth teams, and appeals reviewers; proof=payer-evidence-gap-resolution-rate; next=Add one synthetic payer-policy evidence loop to the competitive demo queue and public-market readiness proof map.
- imaging-to-action-without-interpretation: priority=near-term; audience=radiology operations, referral coordinators, service-line leaders, and safety reviewers; proof=imaging-handoff-audit-coverage; next=Add imaging-to-action synthetic workflow metadata to the Clinical Data Fabric and AI Infrastructure Watchtower.
- audience-specific-revenue-packaging: priority=strategic; audience=founder-led sales, channel partners, investors, clinics, and buyer champions; proof=offer-to-proof-route-completeness; next=Add clean-room competitor-response offers to pricing and sales-operations packets.

## Risk Controls
- Only public source patterns may enter SCRIMED strategy, and every translation must become original SCRIMED language.: Contract check blocks forbidden claims and requires legal extraction language.
- Sales, investor, and PR messages must point to SCRIMED proof routes or explicitly state readiness-only scope.: Market execution lanes bind each message to a proof artifact and retained boundary.
- Any clinical, payer, legal, finance, security, or external communication motion requires human review.: Every lane has humanReviewRequired=true and blocked action coverage.
- No route may request or display PHI, live patient data, secrets, raw connector payloads, or competitor private material.: Safety headers, smoke coverage, and documentation boundaries.

## Blocked Actions
- No PHI or live patient data
- No autonomous diagnosis, treatment, prescribing, triage, or imaging interpretation
- No EHR writeback, payer submission, patient outreach, or billing submission
- No competitor proprietary copying, scraping, reverse engineering, or brand imitation
- No certification, customer go-live, reimbursement, revenue, valuation, or security assurance claim

## Next Build Step
Use the Market Execution Engine as the source of truth for buyer demo scripts, investor pitch proof routes, privacy-safe PR language, and revenue motion prioritization.

This is synthetic/business-metadata execution support only. It does not authorize PHI, autonomous clinical care, payer submission, EHR writeback, certification claims, production connector approval, customer go-live, or competitor proprietary copying.